Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Torrent Pharma Stock Skyrockets 6.65%! Brokerages Hailing Massive Q2 Growth & Future Potential - Investors Rejoicing!

Healthcare/Biotech

|

Updated on 10 Nov 2025, 05:25 pm

Whalesbook Logo

Reviewed By

Aditi Singh | Whalesbook News Team

Short Description:

Torrent Pharmaceuticals reported a strong July-September quarter for FY26, leading to a 6.65% surge in its share price. The company's revenue grew by 14.3% year-on-year, driven by its India business and Rest of the World markets. This performance, coupled with expectations of growth from new launches and synergies, has prompted several brokerages to upgrade their earnings estimates for FY27, boosting investor confidence.
Torrent Pharma Stock Skyrockets 6.65%! Brokerages Hailing Massive Q2 Growth & Future Potential - Investors Rejoicing!

▶

Stocks Mentioned:

Torrent Pharmaceuticals Limited

Detailed Coverage:

Torrent Pharmaceuticals experienced a significant 6.65% increase in its stock price, reaching ₹3,817, following an impressive performance in the July-September quarter of FY26. The company's revenue saw a robust 14.3% year-on-year growth, largely fueled by its strong performance in the Indian market and Rest of the World (ROW) regions. Torrent Pharmaceuticals continues to outpace the domestic market, attributed to its strong foothold in high-growth therapeutic segments.

Impact: This news has a direct positive impact on the Indian stock market, particularly the pharmaceutical sector. It reflects strong operational performance and positive future outlook for a major Indian company, which can boost investor sentiment towards similar stocks. Rating: 7/10


Brokerage Reports Sector

Amber Enterprises Faces Margin Squeeze: ICICI Securities Maintains HOLD But Slashes Target Price!

Amber Enterprises Faces Margin Squeeze: ICICI Securities Maintains HOLD But Slashes Target Price!

Somany Ceramics: ICICI Securities Issues Strong BUY Recommendation with INR 604 Target!

Somany Ceramics: ICICI Securities Issues Strong BUY Recommendation with INR 604 Target!

ICICI Securities Downgrades Divi's Labs to SELL! Target Price Set at ₹5,400 Amid Valuation Concerns

ICICI Securities Downgrades Divi's Labs to SELL! Target Price Set at ₹5,400 Amid Valuation Concerns

NALCO Q2 Earnings Smash Expectations! ICICI Securities Downgrades to HOLD - See New Target Price!

NALCO Q2 Earnings Smash Expectations! ICICI Securities Downgrades to HOLD - See New Target Price!

Kalyan Jewellers India: ICICI Securities Reiterates BUY! INR 670 Target Set Amidst Stellar Q2 Performance & Festive Cheer!

Kalyan Jewellers India: ICICI Securities Reiterates BUY! INR 670 Target Set Amidst Stellar Q2 Performance & Festive Cheer!

Lupin Q2 Earnings Surge! ICICI Securities Eyes 20% Upside - Your Next Big Pharma Investment?

Lupin Q2 Earnings Surge! ICICI Securities Eyes 20% Upside - Your Next Big Pharma Investment?

Amber Enterprises Faces Margin Squeeze: ICICI Securities Maintains HOLD But Slashes Target Price!

Amber Enterprises Faces Margin Squeeze: ICICI Securities Maintains HOLD But Slashes Target Price!

Somany Ceramics: ICICI Securities Issues Strong BUY Recommendation with INR 604 Target!

Somany Ceramics: ICICI Securities Issues Strong BUY Recommendation with INR 604 Target!

ICICI Securities Downgrades Divi's Labs to SELL! Target Price Set at ₹5,400 Amid Valuation Concerns

ICICI Securities Downgrades Divi's Labs to SELL! Target Price Set at ₹5,400 Amid Valuation Concerns

NALCO Q2 Earnings Smash Expectations! ICICI Securities Downgrades to HOLD - See New Target Price!

NALCO Q2 Earnings Smash Expectations! ICICI Securities Downgrades to HOLD - See New Target Price!

Kalyan Jewellers India: ICICI Securities Reiterates BUY! INR 670 Target Set Amidst Stellar Q2 Performance & Festive Cheer!

Kalyan Jewellers India: ICICI Securities Reiterates BUY! INR 670 Target Set Amidst Stellar Q2 Performance & Festive Cheer!

Lupin Q2 Earnings Surge! ICICI Securities Eyes 20% Upside - Your Next Big Pharma Investment?

Lupin Q2 Earnings Surge! ICICI Securities Eyes 20% Upside - Your Next Big Pharma Investment?


IPO Sector

IPO Alert! Payment Card Giant Files for Big Rs 400 Cr Launch - Are You Ready?

IPO Alert! Payment Card Giant Files for Big Rs 400 Cr Launch - Are You Ready?

Lenskart IPO Stuns Dalal Street: Shares Plunge 11%, Then Skyrocket! What's Next for This Unicorn?

Lenskart IPO Stuns Dalal Street: Shares Plunge 11%, Then Skyrocket! What's Next for This Unicorn?

PhysicsWallah IPO Shatters Expectations: Anchor Investors Pour ₹1,562 Cr! Huge Debut Ahead?

PhysicsWallah IPO Shatters Expectations: Anchor Investors Pour ₹1,562 Cr! Huge Debut Ahead?

Secret IPO Doors OPEN! SEBI Approves Pharma & Green Energy Giants – Huge Funds Coming!

Secret IPO Doors OPEN! SEBI Approves Pharma & Green Energy Giants – Huge Funds Coming!

India's Fintech Unicorn Groww's Mega IPO Oversubscribed 17.6x! Valuation Skyrockets to $7 Billion – What Investors Need to Know!

India's Fintech Unicorn Groww's Mega IPO Oversubscribed 17.6x! Valuation Skyrockets to $7 Billion – What Investors Need to Know!

IPO Alert! Payment Card Giant Files for Big Rs 400 Cr Launch - Are You Ready?

IPO Alert! Payment Card Giant Files for Big Rs 400 Cr Launch - Are You Ready?

Lenskart IPO Stuns Dalal Street: Shares Plunge 11%, Then Skyrocket! What's Next for This Unicorn?

Lenskart IPO Stuns Dalal Street: Shares Plunge 11%, Then Skyrocket! What's Next for This Unicorn?

PhysicsWallah IPO Shatters Expectations: Anchor Investors Pour ₹1,562 Cr! Huge Debut Ahead?

PhysicsWallah IPO Shatters Expectations: Anchor Investors Pour ₹1,562 Cr! Huge Debut Ahead?

Secret IPO Doors OPEN! SEBI Approves Pharma & Green Energy Giants – Huge Funds Coming!

Secret IPO Doors OPEN! SEBI Approves Pharma & Green Energy Giants – Huge Funds Coming!

India's Fintech Unicorn Groww's Mega IPO Oversubscribed 17.6x! Valuation Skyrockets to $7 Billion – What Investors Need to Know!

India's Fintech Unicorn Groww's Mega IPO Oversubscribed 17.6x! Valuation Skyrockets to $7 Billion – What Investors Need to Know!